Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate vs dexmedetomidine as adjuvants to ropivacaine for supraclavicular block
IRCT20250730066698N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Aug 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of magnesium sulfate, dexmedetomidine and ropivacaine in upper extremity fracture (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Aug 2025; status: completed.
02
Drugs
magnesium sulfatedexmedetomidineropivacaine
03
Conditions
upper extremity fracture
Beyond the preview
Go deeper on IRCT20250730066698N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250730066698N1.